Neuland Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹776.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 76.54 per cent from ₹439.71 crore. This corresponds to a year-on-year *(YoY) growth of 136.40 per cent.
Operating Profit
Operating Profit stands at ₹307.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.46 per cent from ₹77.13 crore. This corresponds to a year-on-year *(YoY) growth of 501.78 per cent.
PBDT
PBDT stands at ₹312.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.75 per cent from ₹78.39 crore. This corresponds to a year-on-year *(YoY) growth of 456.29 per cent.
Profit Before Tax
Profit Before Tax stands at ₹287.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 427.80 per cent from ₹54.47 crore. This corresponds to a year-on-year *(YoY) growth of 631.53 per cent.
Net Profit
Net Profit stands at ₹212.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 424.21 per cent from ₹40.57 crore. This represents a 664.72 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Neuland Laboratories Ltd Earnings
- YOY
- QOQ
Neuland Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Neuland Laboratories Ltd Research Reports
Neuland Laboratories Ltd Financial Reports
Neuland Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Neuland Labs. | 1.46% | 2.59% | 15.60% | 33.19% | 2.90% | 53.37% |
| Sai Life | -3.18% | -0.07% | 6.81% | 14.26% | 30.32% | 56.66% |
| Piramal Pharma | -0.31% | 1.28% | 5.87% | 14.41% | -4.18% | -12.15% |
| Astrazeneca Phar | 2.75% | 4.33% | 4.76% | 1.60% | 0.09% | 13.61% |
| Natco Pharma | 1.19% | 2.97% | 9.16% | 20.41% | 34.91% | 35.53% |
| Pfizer | -1.18% | -0.82% | -3.01% | -8.30% | -6.86% | -14.20% |
| OneSource Speci. | 0.89% | -2.82% | -0.72% | 34.87% | 13.73% | 1.95% |
Company Info
Company Information
Executive Chairman : D R Rao
Non Executive Director : Christopher M Cimarusti
Vice Chairman & Chief Executive Officer : D Sucheth Rao
Vice Chairman & Managing Director : D Saharsh Rao
Company Sec. & Compli. Officer : Sarada Bhamidipati
Independent Director : Homi Rustam Khusrokhan
Independent Director : Prasad R Menon
Independent Director : Sugata Sircar
Independent Director : Pallavi Joshi Bakhru
Additional Director : Ravi Gopinath